Abstract
To examine the efficacy of ultrasound-mediated gene therapy in the treatment of hepatic cancer, we performed cationic liposome-mediated interferon-β (IFNβ) gene therapy combined with sonoporation, using metastatic hepatic tumors of murine colon cancer. The combination of liposome/DNA treatment and ultrasound gave higher transgene IFNβ expression in Colon26 colon adenocarcinoma cells than that with microbubble/DNA in combination with ultrasound and that with liposome/DNA alone. Cationic liposome-mediated IFNβ gene therapy combined with ultrasound showed an antitumor effect in vitro and combination use of the anticancer drug cis-diamminedichloroplatinum (CDDP) showed a synergistic effect with the IFNβ gene therapy. The survival of mice with metastatic hepatic tumor of Colon26 cells was significantly prolonged by cationic liposome-mediated IFNβ gene therapy alone, and sonoporation had a synergistic effect on prolongation of survival and inhibition of tumor growth rate in these mice. Combination use of CDDP with IFNβ gene therapy also showed a synergistic effect on prolongation of survival and inhibition of tumor growth rate. In conclusion, ultrasound-mediated gene therapy for the treatment of hepatic cancers may be effective in a clinical setting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME . Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996; 7: 1339–1346.
Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K . Induction of cell-membrane porosity by ultrasound. Lancet 1999; 353: 1409.
Ward M, Wu J . Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents. J Acoust Soc Am 1999; 105: 2951–2957.
Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233–1239.
Unger EC, McCreery TP, Sweitzer RH . Ultrasound enhances gene expression of liposomal transfection. Invest Radiol 1997; 32: 723–727.
Vile RG, Russell SJ, Lemoine NR . Cancer gene therapy: hard lessons and new courses. Gene Therapy 2000; 7: 2–8.
Kirn D . Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Therapy 2001; 8: 89–98.
Ra SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148–158.
Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y et al. Growth inhibition of glioma cells transfected with the human β-interferon gene by liposome coupled with a monoclonal antibody. Cancer Res 1990; 50: 7826–7829.
Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M et al. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma. Clin Cancer Res 2003; 9: 1129–1135.
Haga N, Yagi K . An improvement method for entrapment of plasmids in liposomes. J Clin Biochem Nutr 1989; 7: 175–183.
Szoka F, Papahadjopoulos D . Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 75: 4194–4198.
Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M et al. Humana gene therapy for malignant gliomas ( glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum Gene Ther 2004; 15: 77–86.
Koch S, Pohl P, Cobet U, Rainov NG . Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med Biol 2000; 26: 897–903.
Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554–2556.
Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A . Gene therapy for hepatocellular carcinoma (HCC) using sonoporation enhanced by contrast agent. Cancer Gene Ther 2005; 12: 884–889.
Natsume A, Mizuno M, Ryuke Y, Yoshida J . Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Therapy 1999; 6: 1626–1633.
Natsume A, Tsujjimura K, Mizuno M, Takahashi T, Yoshida J . IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma. J Neurooncol 2000; 47: 117–124.
Kageshita T, Mizuno M, Ono T, Matsumoto K, Saida T, Yoshida J . Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes. Melanoma Res 2001; 11: 337–342.
Manome Y, Nakamura M, Ohno T, Furuhata H . Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 2000; 11: 1521–1528.
Michel MS, Erben P, Trojan L, Schaaf A, Kiknavelidze K, Knoll T et al. Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells. Anticancer Res 2004; 24: 2303–2308.
Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA . Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287–2291.
Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. Integration of interferon-α/β signaling to p53 responses in tumor suppression and antiviral defense. Nature 2003; 424: 516–523.
Shimizu M, Akiyama S, Ito K, Kasai Y, Takagi H, Kito M et al. Anti-proliferative effects on human colon cancer cells of combined treatment with cationic liposome-entrapped human interferon-β or –γ gene and anti-cancer drug. J Clin Biochem Nutr 1997; 23: 77–83.
Anwer K, Kao G, Proctor B, Anscombe I, Florack V, Earls R et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Therapy 2000; 7: 1833–1839.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayashi, S., Mizuno, M., Yoshida, J. et al. Effect of sonoporation on cationic liposome-mediated IFNβ gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther 16, 638–643 (2009). https://doi.org/10.1038/cgt.2008.1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2008.1
Keywords
This article is cited by
-
Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer
Journal of Cancer Research and Clinical Oncology (2020)
-
Ultrasound Enhanced PEI-Mediated Gene Delivery Through Increasing the Intracellular Calcium Level and PKC-δ Protein Expression
Pharmaceutical Research (2014)
-
Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors
Cancer Gene Therapy (2012)
-
Advances in Gene Delivery Systems
Pharmaceutical Medicine (2011)